On 17 – 19 November 2015 Artem Andrianov, CEO of Cyntegrity, shares experience and case studies at Partnership in Clinical Trials in Hamburg during a PCT RBM workshop. The topic of the workshop will be dedicated to most burning RBM questions today like:
– What KRIs and KPIs matter?
– How much money do I save by implementing a risk-based approach?
– What is the best implementation strategy for a risk-based approach ?
– How will Health Authorities react if they discover a major or critical finding that was not detected or not addressed through your risk management approach?
And many others.
Register for the PCT and book a meeting with Artem Andrianov their if you are interested in knowing more about RBM, its advantages and risks.